Michele Ammendola Selected Research

Michele Ammendola Research Topics

Disease

24	Neoplasms (Cancer) 01/2021 - 07/2009
8	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2013
7	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2014
7	Stomach Neoplasms (Stomach Cancer) 04/2019 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2014
3	Hyperthermia 01/2020 - 01/2020
3	Rectal Neoplasms (Rectal Cancer) 02/2019 - 01/2014
3	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2009
2	Hypoxia (Hypoxemia) 01/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 09/2020 - 02/2014
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2020
2	Adenocarcinoma 09/2017 - 01/2014
2	Prolapse 09/2014 - 07/2013
2	Hypersensitivity (Allergy) 07/2014 - 01/2014
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021
1	Fibrosarcoma 12/2020
1	Carcinogenesis 09/2020
1	Hypertrophy 01/2020
1	Infarction (Infarctions) 01/2020
1	Liver Failure 01/2019
1	Protein Deficiency 01/2019
1	Ascites 01/2019
1	Wounds and Injuries (Trauma) 02/2017
1	Gangrene 02/2017
1	Infections 02/2017
1	Diabetic Foot 02/2017
1	Lymphatic Metastasis 11/2016
1	Bone Resorption 10/2015
1	Liver Neoplasms (Liver Cancer) 05/2015
1	Myxoma (Myxomas) 07/2014
1	Dermatofibrosarcoma 02/2014
1	Vomiting 12/2013
1	Dermatitis 12/2013
1	Asthenia 12/2013

Drug/Important Bio-Agent (IBA)

21	Tryptases (Tryptase)IBA 01/2021 - 07/2009
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
6	Biological ProductsIBA 01/2021 - 01/2014
4	Gabexate (Foy)IBA 01/2021 - 01/2013
4	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2018 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2013
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 02/2014
3	Peptide Hydrolases (Proteases)FDA Link 04/2017 - 01/2014
3	nafamostatIBA 10/2015 - 01/2013
3	S- (N- monomethoxytritylaminoethyl)- O- (2- chlorophenyl)phosphorothioateIBA 10/2015 - 01/2013
3	Serine Proteases (Serine Protease)IBA 07/2014 - 07/2009
2	masitinibIBA 01/2021 - 10/2015
2	degradable starch microspheresIBA 01/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 10/2015 - 02/2014
1	Ethiodized Oil (Ethiodol)FDA Link 01/2021
1	ParaffinIBA 12/2020
1	Formaldehyde (Formol)FDA Link 12/2020
1	Immunologic Factors (Immunomodulators)IBA 09/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	Intravenous AnestheticsIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Opiate AlkaloidsIBA 01/2020
1	Local AnestheticsIBA 01/2020
1	Anesthetics (Anesthetic Agents)IBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor CIBA 04/2019
1	LigandsIBA 04/2019
1	IronIBA 01/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 09/2017
1	2,2,3,3-tetramethylcyclopropane carboxamideIBA 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Angiogenesis InhibitorsIBA 01/2015
1	PAR-2 ReceptorIBA 07/2014
1	pazopanib FDA Link 02/2014
1	tranilastIBA 01/2014

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2014
2	Transplantation 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020
2	Proctectomy 02/2019 - 01/2016
2	Contraindications 02/2019 - 01/2016
2	Lasers (Laser) 09/2014 - 07/2013
2	Optical Fibers 09/2014 - 07/2013
1	Liver Transplantation 01/2021
1	Colectomy 12/2020
1	Precision Medicine 09/2020
1	Electrodes (Electrode) 01/2020
1	Immunomodulation 01/2020
1	Perioperative Period 01/2020
1	Radiotherapy 01/2020
1	Analgesia 01/2020
1	Operative Time 01/2019
1	Length of Stay 01/2019
1	Surgical Amputation (Amputations) 02/2017
1	Stents 01/2017
1	Salvage Therapy 01/2016